Gepretix 200 mg soft capsules

• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

1. What GEPRETIX 200 mg is and what it is used for
2. What you need to know before you take GEPRETIX 200mg
3. How to take GEPRETIX 200 mg
4. Possible side effects
5. How to store GEPRETIX 200 mg
6. Contents of the pack and other information

The name of your medicine is Gepretix 200 mg soft capsules (called Gepretix in this leaflet). Gepretix contains a female hormone called progesterone and is to be used with another medicine called oestrogen. The combination of Gepretix and oestrogen belong to a group of medicines called hormone replacement therapy (HRT).

Gepretix in combination with an oestrogen is used to reduce the symptoms of the menopause (change of life).

• It is used only in women who still have a womb (uterus).

Gepretix is not a contraceptive.

• As you get near the menopause, the amount of the female hormones oestrogen and progesterone in your body goes down.
• HRT replaces these hormones and helps reduce the symptoms of the menopause.

• If your HRT contains only oestrogen the lining of the womb could build up. This can cause problems.
• By taking Gepretix as well, this makes you shed the womb lining. This prevents these problems happening.
• You might get some bleeding at the end of each month, rather like a period.

The use of HRT carries risks which need to be considered when deciding whether to start taking it, or whether to carry on taking it.

The experience in treating women with a premature menopause (due to ovarian failure or surgery) is limited. If you have a premature menopause the risks of using HRT may be different. Please talk to your doctor.

Before you start (or restart) HRT, your doctor will ask about your own and your family’s medical history. Your doctor may decide to perform a physical examination. This may include an examination of your breasts, your tummy and/or an internal examination, if necessary.

Once you have started on HRT, see your doctor for regular check-ups (at least once a year). At these check-ups, discuss with your doctor the benefits and risks of continuing to take HRT.

Go for regular breast screening, as recommended by your doctor.

Do not take Gepretix if any of the following applies to you. If you are not sure about any of the points below, talk to your doctor or pharmacist before taking Gepretix.

• If you are allergic (hypersensitive) to progesterone or any of the other ingredients of this medicine (listed in section 6).
• If you have ever had breast cancer, or if you are suspecting of having it;
• If you have cancer which is sensitive to oestrogens, such as cancer of the womb lining (endometrium), or if you are suspected of having it;
• If you have any unexplained vaginal bleeding;
• If you have or ever had a blood clot in a vein (thrombosis), such as in the legs (deep venous thrombosis) or in the lungs (pulmonary embolism) or if you have a history of these types of blood clots.
• If you have a blood clotting disorder (such as protein C, protein S, or antithrombin deficiency).
• If you have or recently have had a disease caused by blood clors in the arteries, such as a heart attack, stroke or angina;
• If you have or have ever had a liver disease and your liver function tests have not returned to normal;
• If you have a rare blood problem called “porphyria” which is passed down in families (inherited).
• If you have bleeding in the brain (cerebral haemorrhage);
• If your are breast-feeding (see “Pregnancy and Breast-feeding”)

If any of the above conditions appear for the first time while taking Gepretix, stop taking it at once and consult your doctor immediately.

Talk to your doctor or pharmacist before taking Gepretix.

When to take special care with HRT

Tell your doctor if you have or ever had any of the following problems, before you start the treatment, as these may return or become worse during treatment with HRT. If so, you should see your doctor for more often check-ups:

• Abnormal tumours/growths (fibroids inside your womb);
• Growth of womb lining outside your womb (endometriosis) or a history of excessive growth of the womb lining (endometrial hyperplasia);
• Increased risk of developing blood clots (see “Blood clots in a vein (thrombosis)”);
• Increased risk of getting a oestrogen-sensitive cancer (such as having a mother, sister or grandmother who has had breast cancer);
• High blood pressure;
• Liver problems such as benign tumour;
• Diabetes;
• Gallstones;
• Migraine or severe headaches;
• A disease of the immune system that affects many organs of the body (systemic lupus erythematosus, SLE);
• Epilepsy;
• Asthma;
• A disease affecting the eardrum and hearing (otosclerosis);
• You have ever had depression;
• Your skin is sensitive to light (photo-sensitivity).

Stop taking Gepretix and see a doctor immediately

If you notice any of the following when taking HRT:

• Any of the conditions mentioned in the ‘DO NOT take Gepretix’ section;
• Yellowing of your skin or the whites of your eyes (jaundice). These may be signs of a liver disease;
• A large rise in your blood pressure (symptoms may be headache, tiredness, dizziness);
• Migraine-like headaches which happen for the first time;
• Sudden or gradual, partial or complete loss of vision;
• Proptosis (forward displacement of the eye) or diplopia (double vision);
• Swelling of the optic nerve (papilloedema);
• Eye diseases (retinal vascular lesions);
• If you become pregnant;
• If you notice signs of a blood clot, such as:
  • painful swelling and redness of the legs;
  • sudden chest pain;
  • difficulty in breathing;

For more information, see ‘Blood clots in a vein (thrombosis)’

Note: Gepretix is not a contraceptive. If it is less than 12 months since your last menstrual period or you are under 50 years old, you may still need to use additional contraception to prevent pregnancy. Speak to your doctor for advice.

Excessive thickening of the lining of the womb (endometrial hyperplasia) and cancer of the lining of the womb (endometrial cancer)

Taking oestrogen-only HRT will increase the risk of excessive thickening of the lining of the womb (endometrial hyperplasia) and cancer of the womb lining (endometrial cancer). The progestogen in Gepretix protects you from this extra risk.

Unexpected bleeding

You will have a bleed once a month (so-called withdrawal bleed) while taking Gepretix. But, if you have unexpected bleeding or drops of blood (spotting) besides your monthly bleeding, which:

• Carries on for more than the first 6 months;
• Starts after you have been taking Gepretix more than 6 months;
• Carries on after you have stopped taking Gepretix;

See your doctor as soon as possible

Breast cancer

Evidence suggests that taking combined oestrogen-progestogen and possibly also oestrogen-only HRT increases the risk of breast cancer. The extra risk depends on how long you take HRT. The additional risk becomes clear within a few years. However, it returns to normal within a few years (at most 5) after stopping treatment.

Compare

Women aged 50 to 79 who are not taking HRT, on average, 9 to 17 in 1000 will be diagnosed with breast cancer over a 5-year period. For women aged 50 to 79 who are taking oestrogen-progestogen HRT over 5 years, there will be 13 to 23 cases in 1000 users (i.e. an extra 4 to 6 cases).

Regularly check your breasts. See your doctor if you notice any changes such as:

• Dimpling of the skin;
• Changes in the nipple;
• Any lumps you can see or feel.

Additionally, you are advised to join mammography screening programs when offered to you.

For mammogram screening, it is important that you inform the nurse/healthcare professional who is actually taking the x-ray that you use HRT, as this medication may increase the density of your breasts which may affect the outcome of the mammogram. Where the density of the breast is increased, mammography may not detect all lumps.

Ovarian cancer

Ovarian cancer is rare – much rarer than breast cancer. The use of oestrogen-only or combined oestrogen-progestogen HRT has been associated with slightly increased risk of ovarian cancer.

The risk of ovarian cancer varies with age. For example, in women aged 50 to 54 who are not taking HRT, on average about 2 women in 2000 will be diagnosed with ovarian cancer over a 5-year period. For women who have been taking HRT for 5 years, there will be about 3 cases per 2000 users (i.e. up to 1 extra case).

Blood clots in a vein (thrombosis)

The risk of blood clots in the veins is about 1.3 to 3- times higher in HRT users than in non-users, especially during the first year of taking it.

Blood clots can be serious, and if one travels to the lungs, it can cause chest pain, breathlessness, fainting or even death.

You are more likely to get a blood clot in your veins as you get older and if any of the following applies to you. Inform your doctor if any of these situations applies to you:

• You are unable to walk for a long time because of major surgery, injury or illness (see also section 3, If you need to have surgery);
• You are seriously overweight (BMI >30 kg/m²);
• You have any blood clotting problem that needs long-term treatment with a medicine used to prevent blood clots;
• If any of your close relatives has ever had a blood clot in the leg, lung or another organ;
• You have systemic lupus erythematosus (SLE);
• You have cancer

For signs of a blood clot, see “Stop taking Gepretix and see a doctor immediately”.

Compare

Looking at women in their 50s who are not taking HRT, on average, over a 5-year period, 4 to 7 in 1000 would be expected to get a blood clot in a vein.

For women in their 50s who have been taking oestrogen-progestogen HRT for over 5 years, there will be 9 to 12 cases in 1000 users (i.e.an extra 5 cases).

Heart disease (heart attack)

There is no evidence that HRT will prevent a heart attack.

Women over the age of 60 years who use oestrogen-progestogen HRT are slightly more likely to develop heart disease than those not taking any HRT.

Stroke

The risk of getting stroke is about 1.5 times higher in HRT users than in non-users. The number of extra cases of stroke due to use of HRT will increase with age.

Compare

Looking at women in their 50s who are not taking HRT, on average, 8 in 1000 would be expected to have a stroke over a 5-year period. For women in their 50s who are taking HRT, there will be 11 cases in 1000 users, over 5 years (i.e. an extra 3 cases).

Other conditions

HRT will not prevent memory loss. There is some evidence of a higher risk of memory loss in women who start using HRT after the age of 65. Speak to your doctor for advice.

Children

Gepretix is not for use in children.

Gepretix can affect the way some other medicines work. Also other medicines may interfere with the effect of Gepretix or HRT. This applies to the following medicines:

• Medicines for epilepsy (such as phenobarbital, phenytoin and carbamazepin);
• Medicines for tuberculosis (such as rifampicin, rifabutin);
• Medicines for HIV infection (such as nevirapine, efavirenz, ritonavir and nelfinavir);
• Herbal remedies containing St John’s Wort (Hypericum perforatum);
• Bromocriptine used for problems with the pituitary gland or Parkinson’s Disease.
• Cyclosporin (used to suppress the immune system).
• Ketoconazole (used for fungal infections).
• Water tablets (spironolactone);
• Antibiotics (ampicillins, tetracyclines);
• Antisteroids (medroxyprogesterone acetate, megestrol);
• Medicines to prevent blood clots (such as coumarins, phenindione)
• Diabetic medicines;
• Emergency contraceptives (ulipristal acetate);
• Diazepam
• Tizanidine (used in multiple sclerosis).

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines including medicines obtained without a prescription, herbal medicines or other natural products.

If you need a blood test, tell your doctor or the laboratory staff that you are taking HRT, because HRT can affect the results of some tests.

Do not take Gepretix with food. See Section 3 ‘How to take Gepretix’ for more information on when to take this medicine

• Do not take Gepretix if you are pregnant or might become pregnant.
• Gepretix is for use of postmenopausal women only. If you become pregnant, stop taking Gepretix and contact your doctor.
• Talk to your doctor before taking this medicine if you are breast-feeding.

You may feel sleepy or dizzy while taking Gepretix. If this happens, do not drive or use any tools or machines. Taking Gepretix at bedtime can reduce this effects.

If you are allergic to peanut or soya, do not use this medicinal product.

• Take one capsule at bedtime on days 15 to 26 of your 28- day cycle.
• You will usually have a few days withdrawal bleeding (like a period) after this time.
• Continue to take your oestrogen HRT every day.
• If you have any problems with the withdrawal bleed, your doctor may change the way that you take Gepretix. This will help to reduce the amount of withdrawal bleeding.

If you are going to have surgery, tell the surgeon that you are taking HRT. You may need to stop taking HRT about 4 to 6 weeks before the operation to reduce the risk of a blood clot (see section 2, Blood clot in a vein). Ask your doctor when you can start taking HRT again.

If your take more Gepretix than you should, talk to your doctor or or go to a hospital. Take the medicine pack with you.

The following effects may happen: feeling drowsy, dizzy, sleepy or tired.

• If you forget a dose, take it as soon as you remember it. However, if it is nearly time for the next dose, skip the missed dose.
• Do not take a double dose to make up for a forgotten dose.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the website Yellow Card Scheme on the MHRA website www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card. In the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

The active substance is progesterone. Each capsule contains 200 mg of progesterone.

The other ingredients are grape seed oil and soya bean lecithin.

The capsule itself is made of gelatin, glycerol and titanium dioxide (E171).

See section 2 “GEPRETIX contains lecithin from soya.

200 mg, soft capsules : Ovoid soft gelatine capsules off-white coloured approx. 16 mm long and approx. 9.6 mm wide.

Each blister contains 15 soft capsules.

Each box contains 15, 30, 45, 60 or 90 soft capsules